Anika Therapeutics (ANIK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1990 | 12-1989 | |
| Cash Flows From Operating Activities | ||
| Net Income | -5,647 | -5,647 |
| Depreciation Amortization | 168 | 168 |
| Other Working Capital | 6,029 | 6,029 |
| Operating Cash Flow | $550 | $550 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -74 | -74 |
| Other Investing Activity | -476 | -476 |
| Investing Cash Flow | $-550 | $-550 |
| Cash Flows From Financing Activities | ||
| Financing Cash Flow | $N/A | $N/A |
| Net Cash Flow | $N/A | $N/A |
| Free Cash Flow | ||
| Operating Cash Flow | 550 | 550 |
| Free Cash Flow | 550 | 550 |